Characteristic | DTI N (%) | Non-DTI N (%) | P value |
---|---|---|---|
Sex | 0.42 | ||
Female | 9 (16.1) | 47 (83.9) | |
Male | 49 (12.3) | 351 (87.8) | |
Body mass index (kg/m2) | 0.23 | ||
≤ 18.5 | 3 (17.6) | 14 (82.4) | |
18.6–25.0 | 32 (14.7) | 185 (85.3) | |
25.1–30.0 | 19 (12.3) | 136 (87.7) | |
30.1–35.0 | 2 (4.1) | 47 (95.9) | |
35.1–40.0 | 1 (6.7) | 14 (93.3) | |
≥ 40.1 | 1 (33.3) | 2 (66.7) | |
HNRT | 0.73 | ||
No | 31 (13.2) | 203 (86.8) | |
Yes | 27 (12.2) | 195 (87.8) | |
Mallampati score | 0.032 | ||
1 | 4 (6.5) | 58 (93.5) | |
2 | 19 (9.5) | 182 (90.5) | |
3 | 22 (17.1) | 107 (82.9) | |
4 | 11 (19.6) | 45 (80.4) | |
Mallampati score (1/2 vs. 3/4) | 0.004 | ||
1/2 | 23 (8.7) | 240 (91.3) | |
3/4 | 33 (17.8) | 152 (82.2) | |
Mouth opening | 0.53 | ||
Full | 44 (12.3) | 314 (87.7) | |
Limited | 14 (14.7) | 81 (85.3) | |
Edentulous | 0.42 | ||
Yes | 10 (10.3) | 87 (89.7) | |
No | 48 (13.4) | 310 (86.6) | |
Neck movement | 0.066 | ||
Full range | 44 (11.5) | 337 (88.5) | |
Restricted | 14 (19.4) | 58 (80.6) | |
Cancer stage | 0.58 | ||
T1 | 8 (9.6) | 75 (90.4) | |
T2 | 23 (15.1) | 129 (84.9) | |
T3 | 10 (11.4) | 78 (88.6) | |
T4 | 11 (10.8) | 91 (89.2) |